APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pefloxacin Mesylate for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pefloxacin Mesylate for Injection Industry Growth and Trends Forecast to 2032

27 December 2025124 pages

Choose your research edition.

Industry ResearchPefloxacin Mesylate for Injection Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pefloxacin Mesylate for Injection Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pefloxacin Mesylate for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pefloxacin Mesylate for Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Pefloxacin Mesylate for Injection Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Pefloxacin Mesylate for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pefloxacin Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pefloxacin Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pefloxacin Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pefloxacin Mesylate for Injection include Chengdu Tiantaishan Pharmaceutical Co., Ltd., Furen Pharmaceutical Group Co., Ltd., Guangdong Xinghao Pharmaceutical Co., Ltd., Harbin Sanlian Pharmaceutical Co., Ltd., Harbin Songhe Pharmaceutical Co., Ltd., Haikou Qili Pharmaceutical Co., Ltd., Hainan General Kangli Pharmaceutical Co., Ltd., Hainan Zhuotai Pharmaceutical Co., Ltd. and Hubei Wushi Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pefloxacin Mesylate for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pefloxacin Mesylate for Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pefloxacin Mesylate for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pefloxacin Mesylate for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pefloxacin Mesylate for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pefloxacin Mesylate for Injection Market by Company

Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Furen Pharmaceutical Group Co., Ltd.

Guangdong Xinghao Pharmaceutical Co., Ltd.

Harbin Sanlian Pharmaceutical Co., Ltd.

Harbin Songhe Pharmaceutical Co., Ltd.

Haikou Qili Pharmaceutical Co., Ltd.

Hainan General Kangli Pharmaceutical Co., Ltd.

Hainan Zhuotai Pharmaceutical Co., Ltd.

Hubei Wushi Pharmaceutical Co., Ltd.

Hunan Wuzhoutong Pharmaceutical Co., Ltd.

Hunan Yige Pharmaceutical Co., Ltd.

Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.

Jincheng Haisi Pharmaceutical Co., Ltd.

Ruiyang Pharmaceutical Co., Ltd.

Shandong Phoenix Pharmaceutical Co., Ltd.

Sichuan Sanxingdui Pharmaceutical Co., Ltd.

Yantai Dongcheng North Pharmaceutical Co., Ltd.

Zhejiang Beide Pharmaceutical Co., Ltd.

Zhejiang Asia Pacific Pharmaceutical Co., Ltd.

Zhejiang Zuoli Pharmaceutical Co., Ltd.

Pefloxacin Mesylate for Injection Segment by Type

0.2g/Piece

0.4g/Piece

Pefloxacin Mesylate for Injection Segment by Application

Physical Pharmacies

Clinic

Other

Pefloxacin Mesylate for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pefloxacin Mesylate for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pefloxacin Mesylate for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pefloxacin Mesylate for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pefloxacin Mesylate for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pefloxacin Mesylate for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.2g/Piece Table 2. Major Company of 0.4g/Piece Table 3. Global Pefloxacin Mesylate for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pefloxacin Mesylate for Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Pefloxacin Mesylate for Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Pefloxacin Mesylate for Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pefloxacin Mesylate for Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pefloxacin Mesylate for Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Pefloxacin Mesylate for Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Pefloxacin Mesylate for Injection Industry Trends Table 25. Pefloxacin Mesylate for Injection Industry Drivers Table 26. Pefloxacin Mesylate for Injection Industry Opportunities and Challenges Table 27. Pefloxacin Mesylate for Injection Industry Restraints Table 28. Global Pefloxacin Mesylate for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pefloxacin Mesylate for Injection Revenue Market Share by Company (2021-2026) Table 30. Global Pefloxacin Mesylate for Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Pefloxacin Mesylate for Injection Sales Share by Company (2021-2026) Table 32. Global Pefloxacin Mesylate for Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Pefloxacin Mesylate for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pefloxacin Mesylate for Injection Major Company Production Sites and Headquarters Table 35. Global Pefloxacin Mesylate for Injection Company, Product Type & Application Table 36. Global Pefloxacin Mesylate for Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pefloxacin Mesylate for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pefloxacin Mesylate for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pefloxacin Mesylate for Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Pefloxacin Mesylate for Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pefloxacin Mesylate for Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pefloxacin Mesylate for Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Pefloxacin Mesylate for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Pefloxacin Mesylate for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Pefloxacin Mesylate for Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pefloxacin Mesylate for Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pefloxacin Mesylate for Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Pefloxacin Mesylate for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Pefloxacin Mesylate for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pefloxacin Mesylate for Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Pefloxacin Mesylate for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pefloxacin Mesylate for Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pefloxacin Mesylate for Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pefloxacin Mesylate for Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Pefloxacin Mesylate for Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information Table 72. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview Table 73. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 75. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Development Table 76. Furen Pharmaceutical Group Co., Ltd. Company Information Table 77. Furen Pharmaceutical Group Co., Ltd. Business Overview Table 78. Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 80. Furen Pharmaceutical Group Co., Ltd. Recent Development Table 81. Guangdong Xinghao Pharmaceutical Co., Ltd. Company Information Table 82. Guangdong Xinghao Pharmaceutical Co., Ltd. Business Overview Table 83. Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 85. Guangdong Xinghao Pharmaceutical Co., Ltd. Recent Development Table 86. Harbin Sanlian Pharmaceutical Co., Ltd. Company Information Table 87. Harbin Sanlian Pharmaceutical Co., Ltd. Business Overview Table 88. Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 90. Harbin Sanlian Pharmaceutical Co., Ltd. Recent Development Table 91. Harbin Songhe Pharmaceutical Co., Ltd. Company Information Table 92. Harbin Songhe Pharmaceutical Co., Ltd. Business Overview Table 93. Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 95. Harbin Songhe Pharmaceutical Co., Ltd. Recent Development Table 96. Haikou Qili Pharmaceutical Co., Ltd. Company Information Table 97. Haikou Qili Pharmaceutical Co., Ltd. Business Overview Table 98. Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 100. Haikou Qili Pharmaceutical Co., Ltd. Recent Development Table 101. Hainan General Kangli Pharmaceutical Co., Ltd. Company Information Table 102. Hainan General Kangli Pharmaceutical Co., Ltd. Business Overview Table 103. Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 105. Hainan General Kangli Pharmaceutical Co., Ltd. Recent Development Table 106. Hainan Zhuotai Pharmaceutical Co., Ltd. Company Information Table 107. Hainan Zhuotai Pharmaceutical Co., Ltd. Business Overview Table 108. Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 110. Hainan Zhuotai Pharmaceutical Co., Ltd. Recent Development Table 111. Hubei Wushi Pharmaceutical Co., Ltd. Company Information Table 112. Hubei Wushi Pharmaceutical Co., Ltd. Business Overview Table 113. Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 115. Hubei Wushi Pharmaceutical Co., Ltd. Recent Development Table 116. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Company Information Table 117. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Business Overview Table 118. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 120. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Recent Development Table 121. Hunan Yige Pharmaceutical Co., Ltd. Company Information Table 122. Hunan Yige Pharmaceutical Co., Ltd. Business Overview Table 123. Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 125. Hunan Yige Pharmaceutical Co., Ltd. Recent Development Table 126. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Company Information Table 127. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Business Overview Table 128. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 130. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Recent Development Table 131. Jincheng Haisi Pharmaceutical Co., Ltd. Company Information Table 132. Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview Table 133. Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 135. Jincheng Haisi Pharmaceutical Co., Ltd. Recent Development Table 136. Ruiyang Pharmaceutical Co., Ltd. Company Information Table 137. Ruiyang Pharmaceutical Co., Ltd. Business Overview Table 138. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 140. Ruiyang Pharmaceutical Co., Ltd. Recent Development Table 141. Shandong Phoenix Pharmaceutical Co., Ltd. Company Information Table 142. Shandong Phoenix Pharmaceutical Co., Ltd. Business Overview Table 143. Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 145. Shandong Phoenix Pharmaceutical Co., Ltd. Recent Development Table 146. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Company Information Table 147. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Business Overview Table 148. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 150. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Recent Development Table 151. Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information Table 152. Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview Table 153. Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 155. Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Development Table 156. Zhejiang Beide Pharmaceutical Co., Ltd. Company Information Table 157. Zhejiang Beide Pharmaceutical Co., Ltd. Business Overview Table 158. Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 160. Zhejiang Beide Pharmaceutical Co., Ltd. Recent Development Table 161. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information Table 162. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview Table 163. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 165. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Development Table 166. Zhejiang Zuoli Pharmaceutical Co., Ltd. Company Information Table 167. Zhejiang Zuoli Pharmaceutical Co., Ltd. Business Overview Table 168. Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 170. Zhejiang Zuoli Pharmaceutical Co., Ltd. Recent Development Table 171. North America Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 173. North America Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2026) Table 174. North America Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Pefloxacin Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 176. North America Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Pefloxacin Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Pefloxacin Mesylate for Injection Market Share by Country (2021-2026) Table 179. North America Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Pefloxacin Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 181. Europe Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 183. Europe Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2026) Table 184. Europe Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Pefloxacin Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Pefloxacin Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Pefloxacin Mesylate for Injection Market Share by Country (2021-2026) Table 189. Europe Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Pefloxacin Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Pefloxacin Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Pefloxacin Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Pefloxacin Mesylate for Injection Market Share by Country (2021-2026) Table 199. Asia-Pacific Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Pefloxacin Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 201. Latin America Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 203. Latin America Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2026) Table 204. Latin America Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Pefloxacin Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Pefloxacin Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Pefloxacin Mesylate for Injection Market Share by Country (2021-2026) Table 209. Latin America Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Pefloxacin Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Pefloxacin Mesylate for Injection Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Pefloxacin Mesylate for Injection Market Share by Country (2021-2026) Table 219. Middle East and Africa Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Pefloxacin Mesylate for Injection Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Pefloxacin Mesylate for Injection Distributors List Table 224. Pefloxacin Mesylate for Injection Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Pefloxacin Mesylate for Injection Image Figure 2. Global Pefloxacin Mesylate for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pefloxacin Mesylate for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Pefloxacin Mesylate for Injection Sales (2021-2032) & (K Units) Figure 5. 0.2g/Piece Image Figure 6. Global 0.2g/Piece Sales YoY Growth (2021-2032) & (K Units) Figure 7. 0.4g/Piece Image Figure 8. Global 0.4g/Piece Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Pefloxacin Mesylate for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pefloxacin Mesylate for Injection Market Share by Type 2025 VS 2032 Figure 11. North America Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Pefloxacin Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pefloxacin Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pefloxacin Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pefloxacin Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pefloxacin Mesylate for Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Physical Pharmacies Image Figure 24. Global Physical Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Pefloxacin Mesylate for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pefloxacin Mesylate for Injection Market Share by Application 2025 VS 2032 Figure 31. North America Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Pefloxacin Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pefloxacin Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pefloxacin Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pefloxacin Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Pefloxacin Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Pefloxacin Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pefloxacin Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pefloxacin Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Pefloxacin Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pefloxacin Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pefloxacin Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Pefloxacin Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pefloxacin Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pefloxacin Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Pefloxacin Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pefloxacin Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Pefloxacin Mesylate for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pefloxacin Mesylate for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pefloxacin Mesylate for Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pefloxacin Mesylate for Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.2g/Piece
  • 0.4g/Piece
Applications
  • Physical Pharmacies
  • Clinic
  • Other
Companies covered
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  • Furen Pharmaceutical Group Co., Ltd.
  • Guangdong Xinghao Pharmaceutical Co., Ltd.
  • Harbin Sanlian Pharmaceutical Co., Ltd.
  • Harbin Songhe Pharmaceutical Co., Ltd.
  • Haikou Qili Pharmaceutical Co., Ltd.
  • Hainan General Kangli Pharmaceutical Co., Ltd.
  • Hainan Zhuotai Pharmaceutical Co., Ltd.
  • Hubei Wushi Pharmaceutical Co., Ltd.
  • Hunan Wuzhoutong Pharmaceutical Co., Ltd.
  • Hunan Yige Pharmaceutical Co., Ltd.
  • Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.
  • Jincheng Haisi Pharmaceutical Co., Ltd.
  • Ruiyang Pharmaceutical Co., Ltd.
  • Shandong Phoenix Pharmaceutical Co., Ltd.
  • Sichuan Sanxingdui Pharmaceutical Co., Ltd.
  • Yantai Dongcheng North Pharmaceutical Co., Ltd.
  • Zhejiang Beide Pharmaceutical Co., Ltd.
  • Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
  • Zhejiang Zuoli Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pefloxacin Mesylate for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pefloxacin Mesylate for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pefloxacin Mesylate for Injection Market by Type
  6. 1.3.1 0.2g/Piece
  7. 1.3.2 0.4g/Piece
  8. 1.4 Global Pefloxacin Mesylate for Injection Market Size by Type
  9. 1.4.1 Global Pefloxacin Mesylate for Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pefloxacin Mesylate for Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pefloxacin Mesylate for Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pefloxacin Mesylate for Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pefloxacin Mesylate for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pefloxacin Mesylate for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pefloxacin Mesylate for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pefloxacin Mesylate for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pefloxacin Mesylate for Injection Industry Trends
  2. 2.2 Pefloxacin Mesylate for Injection Industry Drivers
  3. 2.3 Pefloxacin Mesylate for Injection Industry Opportunities and Challenges
  4. 2.4 Pefloxacin Mesylate for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pefloxacin Mesylate for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Pefloxacin Mesylate for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Pefloxacin Mesylate for Injection Price (2021-2026)
  4. 3.4 Global Pefloxacin Mesylate for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pefloxacin Mesylate for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Pefloxacin Mesylate for Injection Company, Product Type & Application
  7. 3.7 Global Pefloxacin Mesylate for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pefloxacin Mesylate for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pefloxacin Mesylate for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pefloxacin Mesylate for Injection Tier 1, Tier 2, and Tier 3
4 Pefloxacin Mesylate for Injection Regional Status and Outlook
  1. 4.1 Global Pefloxacin Mesylate for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pefloxacin Mesylate for Injection Historic Market Size by Region
  3. 4.2.1 Global Pefloxacin Mesylate for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pefloxacin Mesylate for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pefloxacin Mesylate for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pefloxacin Mesylate for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Pefloxacin Mesylate for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pefloxacin Mesylate for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pefloxacin Mesylate for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pefloxacin Mesylate for Injection by Application
  1. 5.1 Pefloxacin Mesylate for Injection Market by Application
  2. 5.1.1 Physical Pharmacies
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Pefloxacin Mesylate for Injection Market Size by Application
  6. 5.2.1 Global Pefloxacin Mesylate for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pefloxacin Mesylate for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pefloxacin Mesylate for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pefloxacin Mesylate for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pefloxacin Mesylate for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pefloxacin Mesylate for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pefloxacin Mesylate for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pefloxacin Mesylate for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  2. 6.1.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  6. 6.1.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Furen Pharmaceutical Group Co., Ltd.
  8. 6.2.1 Furen Pharmaceutical Group Co., Ltd. Company Information
  9. 6.2.2 Furen Pharmaceutical Group Co., Ltd. Business Overview
  10. 6.2.3 Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  12. 6.2.5 Furen Pharmaceutical Group Co., Ltd. Recent Developments
  13. 6.3 Guangdong Xinghao Pharmaceutical Co., Ltd.
  14. 6.3.1 Guangdong Xinghao Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Guangdong Xinghao Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  18. 6.3.5 Guangdong Xinghao Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Harbin Sanlian Pharmaceutical Co., Ltd.
  20. 6.4.1 Harbin Sanlian Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Harbin Sanlian Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  24. 6.4.5 Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Harbin Songhe Pharmaceutical Co., Ltd.
  26. 6.5.1 Harbin Songhe Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Harbin Songhe Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  30. 6.5.5 Harbin Songhe Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Haikou Qili Pharmaceutical Co., Ltd.
  32. 6.6.1 Haikou Qili Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Haikou Qili Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  36. 6.6.5 Haikou Qili Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Hainan General Kangli Pharmaceutical Co., Ltd.
  38. 6.7.1 Hainan General Kangli Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Hainan General Kangli Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  42. 6.7.5 Hainan General Kangli Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Hainan Zhuotai Pharmaceutical Co., Ltd.
  44. 6.8.1 Hainan Zhuotai Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Hainan Zhuotai Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  48. 6.8.5 Hainan Zhuotai Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Hubei Wushi Pharmaceutical Co., Ltd.
  50. 6.9.1 Hubei Wushi Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Hubei Wushi Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  54. 6.9.5 Hubei Wushi Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Hunan Wuzhoutong Pharmaceutical Co., Ltd.
  56. 6.10.1 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  60. 6.10.5 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Hunan Yige Pharmaceutical Co., Ltd.
  62. 6.11.1 Hunan Yige Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Hunan Yige Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  66. 6.11.5 Hunan Yige Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.
  68. 6.12.1 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  72. 6.12.5 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jincheng Haisi Pharmaceutical Co., Ltd.
  74. 6.13.1 Jincheng Haisi Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  78. 6.13.5 Jincheng Haisi Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Ruiyang Pharmaceutical Co., Ltd.
  80. 6.14.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  84. 6.14.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Shandong Phoenix Pharmaceutical Co., Ltd.
  86. 6.15.1 Shandong Phoenix Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Shandong Phoenix Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  90. 6.15.5 Shandong Phoenix Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Sichuan Sanxingdui Pharmaceutical Co., Ltd.
  92. 6.16.1 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  96. 6.16.5 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Yantai Dongcheng North Pharmaceutical Co., Ltd.
  98. 6.17.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  102. 6.17.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Zhejiang Beide Pharmaceutical Co., Ltd.
  104. 6.18.1 Zhejiang Beide Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Zhejiang Beide Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  108. 6.18.5 Zhejiang Beide Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
  110. 6.19.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  114. 6.19.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Zhejiang Zuoli Pharmaceutical Co., Ltd.
  116. 6.20.1 Zhejiang Zuoli Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Zhejiang Zuoli Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  120. 6.20.5 Zhejiang Zuoli Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Pefloxacin Mesylate for Injection Sales by Country
  2. 7.1.1 North America Pefloxacin Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pefloxacin Mesylate for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pefloxacin Mesylate for Injection Market Size by Country
  6. 7.2.1 North America Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pefloxacin Mesylate for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pefloxacin Mesylate for Injection Sales by Country
  2. 8.1.1 Europe Pefloxacin Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pefloxacin Mesylate for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pefloxacin Mesylate for Injection Market Size by Country
  6. 8.2.1 Europe Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pefloxacin Mesylate for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pefloxacin Mesylate for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Pefloxacin Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pefloxacin Mesylate for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pefloxacin Mesylate for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pefloxacin Mesylate for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pefloxacin Mesylate for Injection Sales by Country
  2. 10.1.1 South America Pefloxacin Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pefloxacin Mesylate for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pefloxacin Mesylate for Injection Market Size by Country
  6. 10.2.1 South America Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pefloxacin Mesylate for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Pefloxacin Mesylate for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pefloxacin Mesylate for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pefloxacin Mesylate for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Pefloxacin Mesylate for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pefloxacin Mesylate for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pefloxacin Mesylate for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pefloxacin Mesylate for Injection Value Chain Analysis
  2. 12.1.1 Pefloxacin Mesylate for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pefloxacin Mesylate for Injection Production Mode & Process
  7. 12.2 Pefloxacin Mesylate for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pefloxacin Mesylate for Injection Distributors
  10. 12.2.3 Pefloxacin Mesylate for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst